In 2020 the Healthcare Compliance Packaging Council celebrates its 30th anniversary. In that time, HCPC has witnessed dramatic changes in the pharmaceutical market, and our mission has evolved to meet the changing landscape of the healthcare industry.

In the position, Hideo (Harry) Yonenaga will assume full business responsibility for the growth and expansion of MHI’s advanced line of blister packaging machines.

Driven by increasingly complex supply chains, a lack of enforcement capacity, the expansion of ecommerce and more sophisticated counterfeiters and counterfeiting methods, the FDA estimates that approximately 10% of all pharmaceuticals currently sold globally are illicit.

As 2017 heads toward the final quarter and the time intended for the Drug Supply Chain Security Act (DSCSA) to implement step 1, i.e., all pharma manufacturers distributing only serialized primary containers into the supply chain, we’ve learned a few things.

Pharmaceutical companies continue to adapt to regulations like the FDA’s Drug Supply Chain Security Act (DSCSA) and 21 CFR Part 11.More and more manufacturers are looking at labeling to provide an edge in the face of these challenges.

In 1970, Richard Nixon signed into law the Poison Prevention Packaging Act (PPPA). The act was written in response to a growing number of child poisonings from unintentional ingestion of drugs and other products. The Act was successful, but a lot has changed in the last 47 years.

The recently introduced Bill HR 1245 IH, the ‘‘Affordable and Safe Prescription Drug Importation Act’’ attempts to open the door to lower cost drugs via Canadian pharmacies.

U.S. government-mandated serialization is creating a scramble in the pharmaceutical packaging world. Track and trace solutions must meet Drug Supply Chain Security Act (DSCSA) compliance by November of this year.

Rondo-Pak introduces a shock- and vibration-resistant folding carton that is ideal for steriles or liquids that require extra protection.